These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. At last, a RE-LYable alternative to warfarin for atrial fibrillation. Hankey GJ. Int J Stroke; 2009 Dec; 4(6):454-5. PubMed ID: 19930055 [No Abstract] [Full Text] [Related]
10. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators. Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169 [Abstract] [Full Text] [Related]
16. Dabigatran versus warfarin in patients with atrial fibrillation. Barry M. N Engl J Med; 2009 Dec 31; 361(27):2674; author reply 2675. PubMed ID: 20050385 [No Abstract] [Full Text] [Related]
17. [The results of the RE-lY study promise more effective, safer and easier prevention of embolic complications in patients with non-valvular atrial fibrillation]. Vojácek J. Vnitr Lek; 2009 Nov 31; 55(11):1085-8. PubMed ID: 20017441 [Abstract] [Full Text] [Related]